Gene and Cell Therapy vector - Integrated Gene Therapy Solution

Therapeutic Antibody Services

SMAB Platform

Antibody Drug Discovery

Cell Line Development

Pre-clinical CMC Services

Gene & Cell Therapy

Clinical Plasmid Manufacturing

GMP Plasmid Manufacturing

IND Set Virus Process Development

Clinical Virus Manufacturing

Our Advantages

Experience & Expertise

Our team and leaders have years of experience in global biopharma companies. Our PMs are trained scientists with PhD degree in the US and Europe.

Learn More »

We support flexible collaboration models that fit different projects to meet diversified customer needs. In projects with limited budget, upon request, we take on more roles throughout the project life cycle.

Learn More »

Quality Management

GenScript ProBio developed the distinguishing Phase-appropriate Compliance (PAC) quality system to meet worldwide stringent regulatory standards (including US-FDA/EU-EMA/China-NMPA), which will benefit our customers in a way of high quality, cost-effectiveness, efficiency and credibility.

Learn More »

Capabilities & Capacity

Current capacity: up to 20 GCT IND and 400 L biologics.

Total 16,800 L bioreactors by 2023.

Learn More »

News & Activities

News 2020-10-22

GenScript ProBio Wins Bioprocessing Excellence in CDMO Services from IMAPACLearn More »

News 2020-09-24

GenScript ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program Learn More »

News 2020-09-16

GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc. Learn More »

Activities 2020-09-11

GenScript ProBio American Commercial Head, Kenneth Lee gives interview to The Medicine Maker about How we can help customers optimize their developing and manufacturing processesLearn More »

All News »

About ProBio

GenScript ProBio – Bio-pharmaceutical CDMO

GenScript ProBio is the bio-pharmaceutical CDMO segment of GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

GenScript ProBio’s innovative solutions for antibody drug development include antibody drug discovery, antibody engineering and antibody characterization. In terms of biologics development service, GenScript ProBio has built a regulatory-compliant platform, from stable cell line development to clinical manufacturing services, providing high quality material for IND and clinical trials. GenScript ProBio’s total gene and cell therapy solution covers CMC of plasmid and virus for IND filing as well as clinical manufacturing and commercial manufacturing.

Toward the mission of “Innovation through Collaboration”, GenScript ProBio is committed to helping customers significantly lower R&D costs and building a healthier future.